Catalyst Wire Dossier Catalyst Wire Dossier

ELLIPTA Inhaler (placebo)

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ELLIPTA Inhaler (placebo), covering 2017-02-09 to 2017-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma [Phase 4]

See pricing